logo

Australia Insulin Infusion Pump Market Size (2024 - 2029)

The market size for insulin infusion pumps in Australia is anticipated to experience growth over the forecast period, driven by the increasing need for effective diabetes management. The COVID-19 pandemic highlighted the critical role of diabetes care, as individuals with diabetes faced heightened risks and complications. This has underscored the importance of advanced diabetes management solutions, such as insulin pumps, which are being adopted rapidly in Australia due to the country's robust healthcare system and stringent reimbursement policies. These factors contribute to the expansion of the market, as they facilitate the integration of new technologies to improve patient outcomes.

Home Market Analysis Healthcare Research Medical Devices Research Australia Insulin Infusion Pump Market Market Size

Market Size of Australia Insulin Infusion Pump Industry

Australia Insulin Infusion Pump Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 103.65 Million
Market Size (2029) USD 129.70 Million
CAGR (2024 - 2029) > 4.60 %

Major Players

Australia Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Australia Insulin Infusion Pump Market Analysis

The Australia Insulin Infusion Pump Market size is estimated at USD 99.09 million in 2023, and is expected to reach USD 124 million by 2028, growing at a CAGR of greater than 4.60% during the forecast period (2023-2028).

The insulin infusion pump market in Australia is poised for significant growth, driven by the rising diabetic population and an increasing number of regulatory approvals for insulin pumps.

The prevalence of diabetes is particularly among older people, who often experience multiple comorbidities, making insulin infusion pumps an attractive option for their long-term care. The Australian Bureau of Statistics data, updated as of December 2023, revealed a diabetes prevalence of 37.8% among men and 27.7% among women over 65. Given that diabetes is more prevalent in this age group, the demand for insulin infusion pumps, crucial for precise insulin dosing, is expected to increase.

Government initiatives to alleviate the financial burden on patients relying on insulin pumps are further propelling market growth. In July 2023, the Australian government, in collaboration with key health organizations like the Australian Diabetes Educators Association (ADEA) and the Australian Diabetes Society (ADS), unveiled the Diabetes Australia Group Strategic Plan 2023-2027. This joint effort underscores their commitment to improving the quality of life for individuals with diabetes.

The 2024-25 Union Budget of Australia allocated an additional AUD 3.7 million (USD 2.5 million) to expand the Insulin Pump Program. This move specifically targets financially disadvantaged Australians under 21 with type 1 diabetes, aiming to make insulin infusion pumps more accessible. By expanding the affordability, this initiative is expected to benefit the low to middle-income groups, boosting pump adoption rates and market growth.

The combination of a growing diabetic population, particularly among older people, and supportive government initiatives is set to drive the expansion of the insulin infusion pump market in Australia. These factors collectively enhance the accessibility and adoption of insulin pumps, which is expected to boost market growth in the coming years.

Australia Insulin Infusion Pump Industry Segmentation

An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. 

The Australian insulin infusion pumps market is segmented by component. By component, the market is segmented into pump device, infusion set, and reservoir. The report offers the value (in USD) and volume (units) for all the above segments.

By Component Type
Insulin Pump Device
Infusion Set
Reservoir
By End Users
Hospitals/Clinics
Home Care
Others
Need A Different Region Or Segment?
Customize Now

Australia Insulin Infusion Pump Market Size Summary

The insulin infusion pump market in Australia is poised for growth, driven by the increasing prevalence of diabetes and the rising adoption of advanced diabetes management technologies. Insulin pumps, which offer a continuous or on-demand insulin delivery system, are becoming a preferred choice for individuals with type 1 diabetes, providing near-physiological insulin delivery. The market is supported by Australia's robust healthcare infrastructure and stringent reimbursement and pricing regulations, which facilitate the rapid deployment of these devices. Despite the high cost and limited access for those without private health insurance, government initiatives and subsidies are aimed at expanding access to insulin pump therapy. The market's expansion is further bolstered by the government's focus on preventive health strategies and the efforts of organizations like the Australian Diabetes Society, which advocate for improved diabetes care and education.

The competitive landscape of the insulin infusion pump market in Australia is characterized by the presence of both international and local players, including Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care. These companies are instrumental in driving innovation and providing advanced solutions for diabetes management. Recent government actions, such as subsidizing the Omnipod insulin pumps and expanding access to continuous glucose monitoring products, underscore the commitment to enhancing diabetes care. The market is expected to continue its upward trajectory as the incidence of type 1 diabetes rises and the demand for effective diabetes management solutions increases, despite challenges related to funding and access disparities.

Explore More

Australia Insulin Infusion Pump Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Diabetes Prevalence in Australia

      2. 1.2.2 Government Support Initiatives to Construct the Spread of Diabetes

    3. 1.3 Market Restraints

      1. 1.3.1 Limited Awareness About the Pump and Related-Technology

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size By Values - USD)

    1. 2.1 By Component Type

      1. 2.1.1 Insulin Pump Device

      2. 2.1.2 Infusion Set

      3. 2.1.3 Reservoir

    2. 2.2 By End Users

      1. 2.2.1 Hospitals/Clinics

      2. 2.2.2 Home Care

      3. 2.2.3 Others

Australia Insulin Infusion Pump Market Size FAQs

The Australia Insulin Infusion Pump Market size is expected to reach USD 103.65 million in 2024 and grow at a CAGR of greater than 4.60% to reach USD 129.70 million by 2029.

In 2024, the Australia Insulin Infusion Pump Market size is expected to reach USD 103.65 million.

Australia Insulin Infusion Pump Market Report Snapshots

Australia Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)